Either or both molecular mechanisms could result in one or more downstream anti-cancer effects such as increased tumor cell apoptosis, inhibiting Hedgehog or growth factor signaling between PDAC and PSC cells, and/or suppressing effectors of the RAS, PI3K/Akt or JAK/STAT3 pathways. Here, AKT1 is linked to cancer.